Follicular lymphoma trials in Saudi Arabia

1 trial · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)

  Where

  Dammam, Riyadh

  Age

  18 years and over

  People

  400 worldwide

  Run by

  Celgene

  See details and how to joinNCT06911502 · EU 2024-519152-82-00